Adagio's COVID-19 antibody protects mice and zaps related viruses in lab tests

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Nov 20, 2020 at 11:12 AM.

  1. #1 cafead, Nov 20, 2020 at 11:12 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,973
    Likes Received:
    3
    via Last week, Adagio Therapeutics raised $80 million in a series B financing to speed its COVID-19 antibody into development. This week, it provided some details about how its approach differs from the many other antibodies in development—and showed some hints of efficacy in mice.

    article source
     
    Quote

Reply to Thread